Effect of ticagrelor on the function of tunneled cuffed catheter in maintenance hemodialysis patients

Jianming Shen1, Yanyan Deng1, Liping Wang1

  • 1Department of Nephrology, Renmin Hospital, Hubei University of Medicine, Shiyan, China.

Insights

Ticagrelor did not extend the functional lifespan of tunneled cuffed catheters (TCC) in maintenance hemodialysis (MHD) patients compared to aspirin. The study found TCCs lasted longer in the aspirin group, suggesting ticagrelor may not be optimal for this indication.

Area of Science:

  • Nephrology
  • Vascular Access
  • Pharmacology

Background:

  • Tunneled cuffed catheters (TCC) are crucial for vascular access in maintenance hemodialysis (MHD).
  • Catheter dysfunction, often due to thrombosis, limits TCC lifespan and impacts patient treatment.
  • Antiplatelet therapy is used to maintain catheter patency, but optimal drug choice requires investigation.

Purpose of the Study:

  • To evaluate the efficacy of ticagrelor compared to aspirin in maintaining TCC function and longevity in MHD patients.
  • To assess the impact of ticagrelor on catheter dysfunction, coagulation, and adverse events.

Main Methods:

  • A prospective study enrolled 80 MHD patients with TCCs, divided into a control group (aspirin) and an observation group (ticagrelor).
  • Data collected included catheter lifespan, dysfunction rates, coagulation parameters, and adverse events over the study period.
  • Statistical analysis, including log rank test, was used to compare outcomes between the groups.

Main Results:

  • The median TCC lifespan was significantly longer in the control group (aspirin) compared to the observation group (ticagrelor).
  • Log rank test confirmed a statistically significant difference (p < 0.001) in catheter survival between the groups.
  • While ticagrelor was associated with reduced catheter dysfunction, this did not translate to a longer overall catheter lifespan in this study.

Conclusions:

  • Ticagrelor may reduce TCC dysfunction by preventing thrombosis, but it did not prolong catheter lifespan compared to aspirin in MHD patients.
  • Further research is needed to optimize antiplatelet strategies for TCCs in MHD to balance patency and longevity.
  • The findings suggest that ticagrelor might not be the preferred agent for maintaining TCC function in MHD patients, despite potential benefits in reducing dysfunction.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
98
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
66
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
93
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
92
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
45
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
65